Results 261 to 270 of about 351,718 (359)

Hallmarks of Neuroblastoma—Pathophysiology, Diagnosis, and Therapeutic Interventions

Cancer Nexus, EarlyView.
ABSTRACT Neuroblastoma, the most common extracranial solid tumor in childhood, continues to challenge clinicians and researchers because of its heterogeneous nature and complex pathophysiology. Recent breakthroughs in molecular profiling revealed intricate genetic alterations driving tumor progression, necessitating an updated perspective on the ...
Abhimanyu Thakur, Anne Dijkstra
wiley   +1 more source

The connected past and future of transplantation, with particular emphasis on the liver [PDF]

, 2004
Starzl, TE
core  

In Vivo Luciferin-Luciferase Reaction in Micro-Mini Pigs Using Xenogeneic Rat Bone Marrow Transplantation. [PDF]

Int J Mol Sci
Abe T, Endo K, Hanazono Y, Kobayashi E.
europepmc   +1 more source

Respiratory Syncytial Virus-Induced Acute Lung Injury in Adult Patients with Bone Marrow Transplants

, 1989
Marshall I. Hertz, Janet A. Englund, Dale C. Snover, Peter B. Bitterman, Philip B. McGlave   +4 more
openalex   +1 more source

Model‐Informed Precision Dosing of Busulfan for Children and Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Critical Evaluation of Current PK Models and Dose Recommendations

Clinical Pharmacology &Therapeutics, EarlyView.
Busulfan is administered intravenously in conditioning regimens prior to allogeneic hematopoietic stem cell transplantation (HSCT), with model‐informed precision dosing (MIPD) targeting a 4‐day cumulative AUC of 80–100 mg*hour/L. Three pharmacokinetic (PK) models—Bognar, Langenhorst, and McCune—were evaluated using data with a minimum of 1 and a median
Rashudy F. Mahomedradja, Tim Bognàr, Kaj E. van Schie, Ilse T. Kuipers, Moniek A. de Witte, Jurgen H.E. Kuball, Erfan Nur, Bram J. Wilhelm, Marise R. Heerma van Voss, Linda Franken, Arief Lalmohamed, Eleonora (Noortje) L. Swart, Dave C. de Leeuw, Imke H. Bartelink   +13 more
wiley   +1 more source

Recipient clonal hematopoiesis in allogeneic bone marrow transplantation for lymphoid malignancies. [PDF]

Blood Adv
Imus PH, Pasca S, Tsai HL, Aljawai YM, Cooke KR, Walston JD, Gocke CD, Varadhan R, Jones RJ, Gondek LP.   +9 more
europepmc   +1 more source

Pharmacogenetic Implementation Studies—Lessons Learned From the PREPARE Study

Clinical Pharmacology &Therapeutics, EarlyView.
The Ubiquitous Pharmacogenomics consortium (www.upgx.eu) has recently completed and published the Preemptive Pharmacogenomic Testing for Preventing Adverse Drug Reactions (PREPARE) study on the implementation of panel‐based pharmacogenetic testing. PREPARE has provided interesting lessons for the design, execution, and interpretation of future clinical
Henk‐Jan Guchelaar, Cathelijne H. van der Wouden, Lisanne E. N. Manson, Heshu Abdullah‐Koolmees, Kathrin Blagec, Tanja Blagus, Stefan Böhringer, Erika Cecchin, Ka‐Chun Cheung, Vera H. M. Deneer, Siv Jonsson, Candace Joefield‐Roka, Katja S. Just, Mats O. Karlsson, Lidija Konta, Rudolf Koopmann, Marjolein Kriek, Thorsten Lehr, Christina Mitropoulou, Victoria Rollinson, Rossana Roncato, Matthias Samwald, Elke Schaeffeler, Maria Skokou, Matthias Schwab, Daniela Steinberger, Julia C. Stingl, Roman Tremmel, Richard M. Turner, Mandy H. van Rhenen, Cristina L. Dávila‐Fajardo, Vita Dolžan, George P. Patrinos, Munir Pirmohamed, Gere Sunder‐Plassmann, Giuseppe Toffoli, Jesse J. Swen, Ubiquitous Pharmacogenomics Consortium   +37 more
wiley   +1 more source

Cell migration, chimerism, and graft acceptance [PDF]

, 1992
A.J Demetris, Armstrong, Arnaud-Battandier, Billingham, Billingham, C Ricordi, Calne, Cranston, Davies, Demetris, Demetris, Faustman, Fung, Gjertson, Hart, Ildstad, Iwaki, Kashiwagi, Kashiwagi, Lechler, M Trucco, Markus, Medawar, Monaco, Murase, Murase, Murase, Murase, N Murase, Porter, Prop, Ramsey, Ricordi, S Ildstad, Selby, Singh, Slavin, Starzl, Starzl, Starzl, Steinman, Steinmuller, T.E Starzl, Talmage, Webb, Wilson, Woodruff, Woodruff   +47 more
core   +1 more source

Bone marrow transplantation increases sulfatase activity in somatic tissues in a multiple sulfatase deficiency mouse model. [PDF]

Commun Med (Lond)
Presa M, Pham V, Ray S, Piec PA, Ryan J, Billings T, Coombs H, Schlotawa L, Lund T, Ahrens-Nicklas RC, Lutz C.   +10 more
europepmc   +1 more source

Critical Pitfalls in the Flow Cytometric Analysis of Mast Cells in Patients With Systemic Mastocytosis

Cytometry Part A, EarlyView.
ABSTRACT Systemic mastocytosis (SM) is a neoplastic disease characterized by abnormal mast cell (MC) activation and proliferation. Accurate diagnosis often relies on flow cytometry to detect aberrant CD25, CD2, and CD30 expression on MCs in bone marrow (BM).
Abdulrazzaq Alheraky, Kees Meijer, Marije T. Nijk, Saskia K. Klein, Hanneke N. G. Oude Elberink, Ido P. Kema, André B. Mulder   +6 more
wiley   +1 more source